Relay Therapeutics (RLAY) Other Gross PP&E Adjustments (2020 - 2025)
Historic Other Gross PP&E Adjustments for Relay Therapeutics (RLAY) over the last 6 years, with Q3 2025 value amounting to -$41.6 million.
- Relay Therapeutics' Other Gross PP&E Adjustments rose 2209.27% to -$41.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$41.6 million, marking a year-over-year increase of 2209.27%. This contributed to the annual value of -$33.8 million for FY2024, which is 2120.23% up from last year.
- Per Relay Therapeutics' latest filing, its Other Gross PP&E Adjustments stood at -$41.6 million for Q3 2025, which was up 2209.27% from -$46.2 million recorded in Q2 2025.
- Over the past 5 years, Relay Therapeutics' Other Gross PP&E Adjustments peaked at -$8.2 million during Q4 2021, and registered a low of -$65.2 million during Q3 2022.
- In the last 5 years, Relay Therapeutics' Other Gross PP&E Adjustments had a median value of -$47.2 million in 2022 and averaged -$42.7 million.
- Its Other Gross PP&E Adjustments has fluctuated over the past 5 years, first tumbled by 48516.5% in 2022, then soared by 2209.27% in 2025.
- Quarter analysis of 5 years shows Relay Therapeutics' Other Gross PP&E Adjustments stood at -$8.2 million in 2021, then crashed by 485.16% to -$48.2 million in 2022, then rose by 11.0% to -$42.9 million in 2023, then grew by 21.2% to -$33.8 million in 2024, then decreased by 22.87% to -$41.6 million in 2025.
- Its last three reported values are -$41.6 million in Q3 2025, -$46.2 million for Q2 2025, and -$50.1 million during Q1 2025.